Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Quick Takeaways Human sleep trials used 25 nmol/kg IV for 7 consecutive nights The commonly used 100250 mcg subcutaneous protocol lacks direct clinical validation DSIP demonstrates an unusually wide safety margin in animal and human research Most evidence comes from small 1980s pilot studies, not modern RCTs What DSIP Actually Is (And Why Its Misunderstood) DSIP is a nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of sleeping rabbits
Combined with semaglutide (CagriSema), it demonstrated 20.4% weight loss in the Phase 3 REDEFINE 1 trial, approaching the efficacy of bariatric surgery
Decreased blood flow results in shrinking of the prostate, reducing obstruction and relieving urinary symptoms
Rushing this process can leave undissolved material that affects accurate dosing
Book an appointment and take the first step toward better health
